PRESENILIN-1 IN DEVELOPMENT AND AGING
PRESENILIN-1 在发育和衰老中的作用
基本信息
- 批准号:6540258
- 负责人:
- 金额:$ 29.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-20 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:Mus musculus aging amyloid proteins biological signal transduction cadherins central nervous system developmental neurobiology embryo /fetus tissue /cell culture gene deletion mutation gene expression gene targeting genetically modified animals immunocytochemistry in situ hybridization laboratory mouse membrane transport proteins mutant northern blottings phenotype presenilin protein biosynthesis protein protein interaction protein structure function skin western blottings
项目摘要
Mutations in Presenilin-1 (PS1) are linked to early onset of familial Alzheimer's disease (FAD) and lead to increased production of Abeta42, a peptide that is accumulated during aging and plays a critical role in AD pathogenesis. PS1 is a multi- pass transmembrane protein that is essential for mouse embryonic development and is required for Abeta peptide generation. PS1 also interacts with beta-catenin and has been implicated in regulating beta-catenin stability in vitro. The in vivo function of PS1 in the adult central nervous system and other tissues is poorly understood, due to the early lethal phenotype of the PS1 null mouse. We have reported that transgenic mouse lines expressing either the wild-type human PS1 protein or PS1 containing the A246E FAD mutation, under the neuronal-specific human Thy-1 promoter, can protect the PS1 null mouse against embryonic lethality and simultaneously restore Abeta expression. This "rescue" system allows us to further define PS1 in vivo activities by introducing specific modifications, such as PS1 mutations affecting Abeta synthesis or beta-catenin interaction respectively. It also offers us a unique opportunity to study the effect of PS1 loss-of-function in adult peripheral tissues of existing mice as they are rescued by a neuronal specific expression of the PS1 transgene. Our preliminary data indicate that lack of PS1 expression in the skin of these mice leads to epidermal hyperplasia and neoplasm, suggesting that PS1 may play an important role in skin tissue, possibly through beta-catenin signaling pathway. Our long-term objective is to use our established rescue system to dissect multiple pathways which PS1 seems to participate in vivo. The specific aims of the proposal are: 1] To explore the molecular mechanism of PS1 activity in adult epidermis; 2] To identify the in vivo significance of PS1- beta-catenin interaction; 3] To determine whether the developmental activity and Abeta generating property of PS1 can be differentiated. We believe that these studies will advance our understanding of the physiological function of PS1 and the pathogenic mechanism of Alzheimer's disease.
Presenilin-1(PS1)的突变与家族性阿尔茨海默氏病(FAD)的早期发作有关,并导致Abeta42的产生增加,Abeta42是在衰老过程中积累的肽,在AD发病机理中起关键作用。 PS1是一种多通过的跨膜蛋白,对于小鼠胚胎发育至关重要,是Abeta肽产生所必需的。 PS1还与β-连环蛋白相互作用,并与体外调节β-catenin稳定性有关。 由于PS1无效小鼠的早期致死表型,对成年中枢神经系统和其他组织中PS1的体内功能知之甚少。 我们报道说,在神经元特异性的人THY-1启动子下,表达野生型人PS1蛋白或含有A246E FAD突变的转基因小鼠系可以保护PS1无效小鼠免受胚胎杀伤力,并同时恢复ABETA的表达。这种“救援”系统使我们能够通过引入特定的修饰,例如分别影响ABETA合成或β-catenin相互作用的PS1突变来进一步定义PS1。 它还为我们提供了一个独特的机会,可以研究现有小鼠的成人外周组织PS1功能丧失的影响,因为它们是通过PS1转基因的神经元特异性表达挽救的。 我们的初步数据表明,这些小鼠的皮肤中缺乏PS1表达会导致表皮增生和肿瘤,这表明PS1可能在皮肤组织中起重要作用,可能通过β-catenin信号通路。 我们的长期目标是利用我们既定的救援系统来剖析PS1似乎参与体内的多种途径。 该提案的具体目的是:1]探索成人表皮中PS1活性的分子机制; 2]确定pS1-β-蛋白酶相互作用的体内意义; 3]确定PS1的发展活动和Abeta产生特性是否可以区分。 我们认为,这些研究将提高我们对PS1生理功能的理解和阿尔茨海默氏病的致病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hui Zheng其他文献
Hui Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hui Zheng', 18)}}的其他基金
A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy
tau 蛋白病中 TFEB 和 V-ATPase 介导的溶酶体应激传感途径
- 批准号:
10413975 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
衰老和阿尔茨海默病中的溶酶体调节和信号传导
- 批准号:
10172231 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
衰老和阿尔茨海默病中的溶酶体调节和信号传导
- 批准号:
10413970 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy
tau 蛋白病中 TFEB 和 V-ATPase 介导的溶酶体应激传感途径
- 批准号:
10583544 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
A TFEB and V-ATPase-mediated lysosomal stress sensing pathway in tauopathy
tau 蛋白病中 TFEB 和 V-ATPase 介导的溶酶体应激传感途径
- 批准号:
10172236 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
衰老和阿尔茨海默病中的溶酶体调节和信号传导
- 批准号:
10765848 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
衰老和阿尔茨海默病中的溶酶体调节和信号传导
- 批准号:
10655043 - 财政年份:2021
- 资助金额:
$ 29.9万 - 项目类别:
相似国自然基金
益智颗粒有效组分(TS)对快速老化痴呆模型小鼠SAMP8大脑β淀粉样蛋白代谢通路影响的研究
- 批准号:
- 批准年份:2020
- 资助金额:33 万元
- 项目类别:
基于环状RNA探讨三七总皂苷调控快速老化模型小鼠SAMP8脑内β淀粉样蛋白形成的机制研究
- 批准号:81660644
- 批准年份:2016
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
电压门控性钠离子通道2B(SCN2B)在脑老化认知功能减退过程中对APP及Nav1.6的调控机制研究
- 批准号:81560238
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
Aβ42通过甲酰肽样受体-1造成神经干/前体细胞老化
- 批准号:81270432
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
三七总皂苷对快速老化痴呆模型小鼠SAMP8大脑β淀粉样蛋白代谢通路影响的研究
- 批准号:30960489
- 批准年份:2009
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
- 批准号:
10555723 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 29.9万 - 项目类别: